S C Aronoff - Concepedia

Author

S C Aronoff

Case Western Reserve University

Also Known As

S C Aronoff, S. C. Aronoff, S.C. Aronoff, Stepben C. Aronoff

Publications

379

Citations

H-Index

Concepts

All Affiliations

Case Western Reserve University Rainbow Babies & Children's Hospital

About

S C Aronoff is an author at Case Western Reserve University specializing in medicine, antimicrobial resistance, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	302
2	Health Sciences	7	7	285
3	Microbiology	3	3	232
4	Pharmacology	3	3	232
5	Hospital Medicine	1	1	11

S C Aronoff

Publications

367

Citations

H-Index

Page 1

	Year	Citations
Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin S C Aronoff, M R Jacobs, S Johenning, Antimicrobial Agents and Chemotherapy PharmacotherapyAntimicrobial ChemotherapyAntibiotic ResistanceDrug ResistanceSodium Clavulanate	1984	123
Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli M R Jacobs, S C Aronoff, S Johenning, Antimicrobial Agents and Chemotherapy Beta-lactamase InhibitorsYtr 830Antimicrobial SusceptibilityHealth SciencesAntibiotics	1986	95
Factors that Influence the Evolution of -Lactam Resistance in -Lactamase--Inducible Strains of Enterobacter cloacae and Pseudomonas aeruginosa S C Aronoff, David M. Shlaes The Journal of Infectious Diseases	1987	52
Antimicrobial therapy of childhood skeletal infections. Peter V. Scoles, S C Aronoff Journal of Bone and Joint Surgery AntibioticsPediatricsAntimicrobial ChemotherapyAntimicrobial PharmacokineticsInfection Control	1984	17
Efficacy and safety of ceftriaxone in serious pediatric infections S C Aronoff, D E Murdell, C A O'Brien, Antimicrobial Agents and Chemotherapy Anti-infective AgentsAntimicrobial SusceptibilityHealth SciencesAntimicrobial StewardshipPediatrics	1983	15
Development of Meningitis During Therapy with Cefamandole S C Aronoff, W. Thomford, Joseph Bertino, PEDIATRICS Cefamandole NafateBacterial PathogensDrug ResistanceAntimicrobial StewardshipCerebrospinal Fluid	1981	14
Developmental pharmacokinetics of moxalactam Michael D. Reed, S C Aronoff, Carolyn M. Myers, Antimicrobial Agents and Chemotherapy Drug SafetySteady StateHealth SciencesMoxalactam EliminationMedicine	1983	14
Sultamicillin in the treatment of superficial skin and soft tissue infections in children Johanna Goldfarb, S C Aronoff, Adam Jaffé, Antimicrobial Agents and Chemotherapy Soft Tissue InfectionsAntibiotic AdjuvantSuperficial SkinDermatologyDrug Resistance	1987	13
Efficacy and Safety of Sequential Treatment with Parenteral Sulbactam/Ampicillin and Oral Sultamicillin for Skeletal Infections in Children S C Aronoff, Peter V. Scoles, Jobn T. MakJey, Clinical Infectious Diseases	1986	13
Ceftazidime as initial therapy for suspected bacterial infections in hospitalized pediatric patients Michael D. Reed, C A O'Brien, S C Aronoff, Antimicrobial Agents and Chemotherapy Klebsiella PneumoniaeAntimicrobial ChemotherapyCeftazidime AdministrationDrug ResistanceHospital Medicine	1984	11

Page 1